Title | Nontoxic, double-deletion-mutant rabies viral vectors for retrograde targeting of projection neurons. |
Publication Type | Journal Article |
Year of Publication | 2018 |
Authors | Chatterjee S, Sullivan HA, MacLennan BJ, Xu R, Hou YY, Lavin TK, Lea NE, Michalski JE, Babcock KR, Dietrich S, Matthews GA, Beyeler A, Calhoon GG, Glober G, Whitesell JD, Yao S, Cetin A, Harris JA, Zeng H, Tye KM, R Reid C, Wickersham IR |
Journal | Nat Neurosci |
Volume | 21 |
Issue | 4 |
Pagination | 638-646 |
Date Published | 2018 Apr |
ISSN | 1546-1726 |
Abstract | Recombinant rabies viral vectors have proven useful for applications including retrograde targeting of projection neurons and monosynaptic tracing, but their cytotoxicity has limited their use to short-term experiments. Here we introduce a new class of double-deletion-mutant rabies viral vectors that left transduced cells alive and healthy indefinitely. Deletion of the viral polymerase gene abolished cytotoxicity and reduced transgene expression to trace levels but left vectors still able to retrogradely infect projection neurons and express recombinases, allowing downstream expression of other transgene products such as fluorophores and calcium indicators. The morphology of retrogradely targeted cells appeared unperturbed at 1 year postinjection. Whole-cell patch-clamp recordings showed no physiological abnormalities at 8 weeks. Longitudinal two-photon structural and functional imaging in vivo, tracking thousands of individual neurons for up to 4 months, showed that transduced neurons did not die but retained stable visual response properties even at the longest time points imaged. |
DOI | 10.1038/s41593-018-0091-7 |
Alternate Journal | Nat. Neurosci. |
PubMed ID | 29507411 |
Grant List | U01 MH106018 / MH / NIMH NIH HHS / United States |
Submitted by kej2006 on June 6, 2018 - 4:13pm